- Home
- CRDF vs OXSQ Comparison
CRDF vs OXSQ Comparison
Compare CRDF & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRDF | OXSQ |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.9M | 151.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRDF | OXSQ |
|---|---|---|
| Price | $2.87 | $1.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.83 | N/A |
| AVG Volume (30 Days) | 980.0K | ★ 1.2M |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 22.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $501,000.00 | ★ $40,142,565.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.90 | $1.56 |
| 52 Week High | $4.99 | $2.87 |
Technical Indicators
Market Signals| Indicator | CRDF | OXSQ |
|---|---|---|
| Relative Strength Index (RSI) | 54.05 | 53.25 |
| Support Level | $2.72 | $1.82 |
| Resistance Level | $3.02 | $1.98 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 37.58 | 50.98 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.